An Outpatient Study Investigating Non-prescription Treatments for COVID-19

• Status: Recruiting
• Trial end date: 2021-03-31
• Target enrollment: 0
• Participant gender: All

Summary

This is a platform study to investigate the effectiveness of a variety of non-prescription approaches for the treatment of non-hospitalized adults recently tested positive for COVID-19.

• Phase: Phase 2
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Profact, Inc.
• Treatments: Chlorine dioxide; Famotidine; Lactoferrin

Criteria

Inclusion Criteria:

1. Signed and dated informed consent form

2. Stated willingness to comply with all study procedures and availability for the duration of the study

3. Male or female, aged 20-70

4. Confirmed diagnosis of COVID-19 by positive COVID-19 test. Symptoms of a mild degree such that hospitalization is not required. Within 7 days of symptom onset.

5. Ability to drink at least 1 liter of water daily and be willing to adhere to the study regimen

Exclusion Criteria:

1. COVID-19 symptoms of a severe enough nature that requires hospitalization

2. Pregnancy or lactation

3. Diagnosis of diabetes mellitus

4. currently taking paroxetine or digoxin

5. Individuals with diabetes mellitus